Moderna to charge Rs 1855-Rs 2755 for COVID-19 vaccine: CEO

Henrietta Strickland
November 22, 2020

Hours after the United States pharmaceutical giant Moderna said it would charge governments between $25 and $37 per dose for its COVID-19 vaccine candidate, Russian drugmaker Sputnik V claimed that its vaccine would be cheaper than those of Pfizer and Moderna.

Talking to German weekly Welt am Sonntag (WamS), Barcel said that the price of the coronavirus vaccine will depend on the amount of doses ordered by the governments.

Last Monday (Nov 16), an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine candidate for a price below US$25 per dose. "We want to deliver to Europe and are in constructive talks", Bancel told WamS, adding that a contract would be signed soon. "Filing in the USA represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential".

Based on these interim safety and efficacy data, Moderna intends to submit for an Emergency Use Authorisation (EUA) with the US Food and Drug Administration (USFDA) in the coming weeks and anticipates having the EUA informed by the final safety and efficacy data.

FDA vaccine advisors reportedly will meet December 8 to 10 to discuss approving vaccines which Pfizer and Moderna say are at least 95 percent effective.

Other reports by Click Lancashire

Discuss This Article